/other/Diamyd_Medical_AB_publ-logo.png?Expires=1749709047&Signature=NQW17Vykf4-2gJmi4KPMY9OEEp-oeWgDOnooTI-GPBcaGPNmb2iCb-tTS0ehZScGHR55JrPJNYqoJT89zY3Cvr0XhYyIcRJnmn41IgSGYt9gQnGiqQ7jKAz7zizEcaSCLO-Nuu4d6EPBIzeShxMD4eKnvBmK1kGrQFPz1n~OjErKwVVw~UDTE9cLpx33~vz3~gzTV4YFtdRZrSE-5ThgcUjXNc0MZu~Ldt98GQGJnw97CpbqAyzx2r6aiEOi3z0~52F~o2spNAy4g2NTKXVh5yl9ZuuaYXC0QqVHqwe2Efj-VeMPWG7RGgPyUEOByEf53RwteammQX6M6h1yBCCcCw__&Key-Pair-Id=K6QMJA61RGOXQ){kind=logo}
Diamyd Medical AB (publ)
DMYD | FN
Overview
Corporate Details
- ISIN(s):
- SE0005162872 (+5 more)
- LEI:
- 5493003NP2HNQDEKB804
- Country:
- Sweden
- Address:
- BOX 7349, 103 90 STOCKHOLM
- Website:
- N/A
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Diamyd Medical AB is a biotech company working on precision medicine for autoimmune diabetes. They are developing antigen-specific immunotherapies.
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Cyclezyme AB | Sweden | CYCLE | |
|
Cyxone AB | Sweden | CYXO | |
|
DBV Technologies | France | DBV | |
|
DEINOVE | France | ALDEI | |
|
Deutsche Biotech Innovativ AG | Germany | DBI | |
|
Devyser Diagnostics | Sweden | DVYSR | |
|
Diasorin | Italy | DIA | |
| DNA Group (T.R.) Ltd. | Israel | DNA | ||
|
Double Bond Pharmaceutical International AB | Sweden | DBP B | |
|
Eckert & Ziegler Strahlen- und Medizintechnik AG | Germany | EUZ |